Problems of antibacterial therapy of hospital infections in the post-pandemic period of COVID-19 and ways to solve them

Author:

Galitsky A. A.1,Mitrokhin S. D.1,Shkoda A. S.1,Orlova O. E.1,Bochkareva S. S.2,Kiseleva I. A.2,Anurova M. N.3,Aleshkin A. V.2

Affiliation:

1. L.A. Vorohobov City Clinical Hospital No. 67, Moscow Healthcare Department

2. G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Federal Service for Supervision of Consumer Rights Protection and Human Welfare

3. G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Federal Service for Supervision of Consumer Rights Protection and Human Welfare; I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Abstract

Due to the coronavirus pandemic in Russia, a significant increase in the emergence of strains of microorganisms with multiple drug resistance was noted.Objective: improvement of the effectiveness of prophylactic and therapeutic measures aimed at prevention of hospital pathogens circulation in the intensive care unit by using bacteriophages active against multidrug-resistant strains of Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii.Materials and methods. The study was conducted on the basis of the Intensive Care Unit No. 2 of L.A. Vorohobov City Clinical Hospital No. 67 of Moscow Healthcare Department. Personalized selection of bacteriophages was carried out on the basis of G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology. The study included two groups of patients, a total of 20 people, who were on prolonged mechanical ventilation in the intensive care unit.Results. No toxic and allergic reactions were detected from the patients in all cases of bacteriophages application. Pathological changes of blood biochemical parameters were not observed in connection with the use of bacteriophages. Complete eradication of pathogens occurred in 60 % of cases.Conclusion. The effectiveness of treatment of various nosological forms of HAIs caused by MDR strains of hospital pathogens increased by 30%, and the effectiveness of the starting antibiotic therapy regimen was 70% and more as a result of the use of personalized phage therapy.

Reference12 articles.

1. Tapal'skiy D. V., Karpova E. V., Akulenok O. M., Okulich V. K., Generalov I. I., Leskova N. Yu., Antonova E. G., Zhil'tsov I. V., Osipkina O. V., Mozharovskaya L. V., Baranov O. Yu. Antibiotic resistance of Klebsiella pneumoniae against the background of the COVID-19 pandemic: experience of the multidisciplinary hospital. Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious Diseases: News, Opinions, Training. 2021; 10 (3): 15–22. doi: 10.33029/2305-3496-2021-10-3-15-22. (In Russ.).

2. Karnouh K. I., Lazareva N. B. Analysis of the antibiotic consumption on the backdrop of the COVID-19 pandemic: hospital level. Meditsinskiy Sovet = Medical Concil. 2021; 16: 118–128. doi: 10.21518/2079-701X-2021-16118-128. (In Russ.).

3. Zhukova E. V., Burova A. A., Mirskaya M. A., Nikitina G. Yu., Semenenko A. V. Structure and antibiotic resistance of bacterial pathogens in high-risk departments of healthcare-associated infections during the COVID-19 pandemic. Sanitarnyy vrach = Sanitary Doctor. 2022; (11): 821–832. doi: 10.33920/med-08-2211-03. (In Russ.).

4. Bahçe Y. G., Acer Ö., Özüdoğru O. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions. Microbial pathogenesis. 2022; 164: 105409. doi: 10.1016/j.micpath.2022.105409.

5. Mitrokhin S. D., Orlova O. E., Yankovskaya O. S., Gosteva I. V., Galitskiy A. A., Karpova I. V., Vedyashkina S. G., Shkoda A. S. Real-life antimicrobial therapy in hospitalized patients with COVID-19 (preliminary results and recommendations). Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical microbiology and antimicrobial chemotherapy. 2022; 24 (2): 181–192. doi: 10.36488/cmac.2022.2.181-192. (In Russ.).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3